A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 7, Pages 3915
Publisher
MDPI AG
Online
2022-04-02
DOI
10.3390/ijms23073915
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD
- (2021) Eric Yuk Fai Wan et al. Clinical Journal of the American Society of Nephrology
- Renin-angiotensin system and inflammation update
- (2021) Elena Cantero-Navarro et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial
- (2021) Peter Rossing et al. DIABETES OBESITY & METABOLISM
- Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
- (2021) Rajiv Agarwal et al. EUROPEAN HEART JOURNAL
- Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- (2021) Rajiv Agarwal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy
- (2020) Didier Collard et al. HYPERTENSION
- Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial
- (2020) Meg J. Jardine et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association of glomerular hyperfiltration with serum chemokine levels and metabolic features in prepubertal children with overweight/obesity
- (2020) María L. Muzzio et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
- (2020) So Ra Kim et al. Nature Communications
- Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
- (2020) Andrew Gibson et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial
- (2020) Hitoshi Minakuchi et al. Scientific Reports
- Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review
- (2020) Li Zhang et al. World Journal of Diabetes
- Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis
- (2019) Ricky D. Turgeon et al. PLoS One
- Renal response to an oral protein load in patients with central diabetes insipidus before and after treatment with vasopressin
- (2019) Davide Viggiano et al. JOURNAL OF NEPHROLOGY
- Effect of tocilizumab, an interleukin-6 inhibitor, on early stage streptozotocin-induced diabetic nephropathy in rats
- (2019) Aly M. Abdelrahman et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function
- (2019) Hiroki Kobayashi et al. HYPERTENSION
- Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes
- (2019) Yutian Lei et al. Frontiers in Immunology
- Does the temporary decrease in the estimated glomerular filtration rate (eGFR) after initiation of mineralocorticoid receptor (MR) antagonist treatment lead to a long-term renal protective effect?
- (2019) Atsuhisa Sato HYPERTENSION RESEARCH
- Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages
- (2019) Yi-Hsuan Lin et al. Frontiers in Endocrinology
- Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
- (2018) Marie E. Edwards et al. Clinical Journal of the American Society of Nephrology
- Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
- (2018) Davide Viggiano et al. KIDNEY & BLOOD PRESSURE RESEARCH
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
- (2018) Fouad T. Chebib et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Can We DECLARE a Victory against Cardio-Renal Disease in Diabetes?
- (2018) Kim A. Connelly et al. Cell Metabolism
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
- (2017) Tsung-Ming Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
- (2017) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus
- (2017) Yayoi Nishida et al. Drugs in research & development
- Glomerular filtration rate in patients with psoriasis treated with etanercept
- (2016) Paolo Gisondi et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduction of Tubular Flow Rate as a Mechanism of Oliguria in the Early Phase of Endotoxemia Revealed by Intravital Imaging
- (2015) D. Nakano et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial
- (2015) Ron T. Gansevoort et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study
- (2014) Lawrence A. Leiter et al. DIABETES CARE
- Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials
- (2014) M. V. Irazabal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease
- (2014) Hyun Woo Kim et al. RHEUMATOLOGY INTERNATIONAL
- Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease
- (2013) Olivier Devuyst et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
- (2013) Wendy E. Boertien et al. KIDNEY INTERNATIONAL
- PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation
- (2012) S Iovino et al. CELL DEATH AND DIFFERENTIATION
- Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
- (2012) A. B. Chapman et al. Clinical Journal of the American Society of Nephrology
- Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
- (2012) P. Ruggenenti et al. DIABETES CARE
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab treatment in patients with rheumatoid arthritis with renal insufficiency
- (2012) Keiichi Sumida et al. ARTHRITIS CARE & RESEARCH
- Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience
- (2011) E. Higashihara et al. Clinical Journal of the American Society of Nephrology
- Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
- (2011) Kathrin Eller et al. DIABETES
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder
- (2011) Eduardo Slatopolsky KIDNEY INTERNATIONAL
- Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
- (2011) Maria V. Irazabal et al. KIDNEY INTERNATIONAL
- The HALT Polycystic Kidney Disease Trials: Design and Implementation
- (2010) A. B. Chapman et al. Clinical Journal of the American Society of Nephrology
- Rate of Kidney Function Decline Associates with Mortality
- (2010) Z. Al-Aly et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum cystatin C level in patients with rheumatoid arthritis after single infusion of infliximab
- (2010) M. Kopec-Medrek et al. RHEUMATOLOGY INTERNATIONAL
- The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease
- (2009) A. K. Ahmed et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search